Nevada Psychiatric Association - 21st Annual Psychopharmacology Update

Event contact title
Sponsorship & Exhibitor Sales:
Event contact first name
Event contact last name
Event contact telephone number
(516) 381-8613
The NPA Psychopharmacology Conference provides comprehensive state-of-the-art information on the psychopharmacological treatment of psychiatric disorders most commonly encountered in clinical practice. This conference will address indications, contraindications, and management of adverse events. It includes a focus on complex and challenging conditions, atypical presentations and special populations through the life cycle. All topics are applicable to the practice of clinicians who prescribe psychotropic medications. Sessions and symposia are presented by internationally recognized faculty from the nation?s leading institutions, who are authorities on various topics at the forefront of modern psychiatry.??The Nevada Psychiatric Association has built the largest annual psychopharmacology conference in the U.S
Attendee information
The Annual Psychopharmacology Conference is designed to meet the continuing education needs of: ? Psychiatrists ? Primary Care Physicians ? Nurse Practitioners & Psychiatric Nurses ? Physician Assistants
Exhibitor information
The Annual Psychopharmacology Conference gives attendees an opportunity to meet with the leading providers of: ? Pharmaceutical products ? Therapeutic products ? Educational materials ? Recruitment services ? Training programs ? Medical and rehabilitation services ? Publications ? Practice management ? Support services

Partner Voices

Until recently, the opportunity to have a celebrity attend an event, attach themselves to a name-brand or endorse a certain product or idea was untouchable. The thought of paying a person to promote a product was seen as something only Fortune 500 companies could afford. Social media has changed all that with brands and businesses utilizing celebrity influencers to connect directly with their demographics and increase sales and profits.